Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 2/2016

01.03.2016 | Laboratory Investigation

Effects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbits

verfasst von: Momoko Nakamura-Shibasaki, Miftahul Akhyar Latief, Ji-ae Ko, Kunihiko Funaishi, Yoshiaki Kiuchi

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the effects of signals through adrenergic receptors on the changes in the aqueous flare and intraocular pressure (IOP) induced by topical prostaglandin E2 (PGE2) in pigmented rabbits.

Methods

Adrenergic agents were applied topically to pigmented Dutch rabbits, and PGE2 was then applied to induce an increase in the aqueous flare and IOP. The degree of aqueous flare was measured with a laser flare meter, and the IOP was measured with a rebound tonometer. Measurements were made every 30 min after the PGE2 had been applied for 2 h and at 4.0 and 4.5 h. Repeated measure analysis of variance and Dunnett’s post hoc tests were used for the statistical analyses.

Results

The topical application of PGE-2 increased the aqueous flare for more than 4.5 h. The topical instillation of 1.0 % apraclonidine significantly inhibited the increase in the PGE2-induced aqueous flare by 75.1 %, of 0.1 % brimonidine by 57.2 %, of 0.04 % dipivefrin by 57.4 %, and a combination of 0.1 % brimonidine and 5 % phenylephrine by 78.9 %. Topical 5.0 % phenylephrine and 0.05 % isoproterenol had little effect on the aqueous flare elevation induced by PGE2. The IOP increased 0.5 h after the topical application of PGE-2. Topical 1.0 % apraclonidine, 0.1 % brimonidine, 0.1 % dipivefrin, and the combination of 0.1 % brimonidine and 5.0 % phenylephrine significantly inhibited the PGE2-induced IOP elevation. However, topical 5.0 % phenylephrine and 0.05 % isoproterenol did not significantly inhibit the IOP elevation caused by PGE2.

Conclusions

Signaling by the α2 receptor inhibits both the PGE2-induced flare and IOP elevation caused by topical PGE2 application.
Literatur
1.
Zurück zum Zitat Allingham RR, Damji KF, Freedman SF, Moroi SE, Rhee DJ. Adrenergic stimulators. Shields textbook of glaucoma, vol. 6th. Philadelphia: Lippincott Williams &Wilkins; 2011. p. 424–7. Allingham RR, Damji KF, Freedman SF, Moroi SE, Rhee DJ. Adrenergic stimulators. Shields textbook of glaucoma, vol. 6th. Philadelphia: Lippincott Williams &Wilkins; 2011. p. 424–7.
2.
Zurück zum Zitat Van Buskirk EM. The ciliary vasculature and its perturbation with drugs and surgery. Trans Am Ophthalmol Soc. 1988;86:794–841.PubMedCentralPubMed Van Buskirk EM. The ciliary vasculature and its perturbation with drugs and surgery. Trans Am Ophthalmol Soc. 1988;86:794–841.PubMedCentralPubMed
3.
Zurück zum Zitat Gharagozloo NZ, Relf SJ, Brubaker RF. Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology. 1988;95:1217–20.CrossRefPubMed Gharagozloo NZ, Relf SJ, Brubaker RF. Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology. 1988;95:1217–20.CrossRefPubMed
4.
Zurück zum Zitat Toris CB, Tafoya ME, Camras CB, Yablonski ME. Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology. 1995;102:456–61.CrossRefPubMed Toris CB, Tafoya ME, Camras CB, Yablonski ME. Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology. 1995;102:456–61.CrossRefPubMed
5.
Zurück zum Zitat Burke J, Schwartz M. Preclinical evaluation of brimonidine. Surv Ophthalmol. 1996;41(Suppl 1):S9–18.CrossRefPubMed Burke J, Schwartz M. Preclinical evaluation of brimonidine. Surv Ophthalmol. 1996;41(Suppl 1):S9–18.CrossRefPubMed
6.
Zurück zum Zitat Burke J, Manlapaz C, Kharlamb A, Runde E, Padillo E, Spada C, et al. Therapeutic use of α 2-adrenoceptor agonists in glaucoma. In: Lanier S, Limbird L, editors. α2-adrenergic receptors: structure, function and therapeutic implications. New York: Reading: Harwood Academic Publishers; 1996. p. 179–87. Burke J, Manlapaz C, Kharlamb A, Runde E, Padillo E, Spada C, et al. Therapeutic use of α 2-adrenoceptor agonists in glaucoma. In: Lanier S, Limbird L, editors. α2-adrenergic receptors: structure, function and therapeutic implications. New York: Reading: Harwood Academic Publishers; 1996. p. 179–87.
7.
Zurück zum Zitat Toris CB, Gleason ML, Camras CB, Yablonski ME. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol. 1995;113:1514–7.CrossRefPubMed Toris CB, Gleason ML, Camras CB, Yablonski ME. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol. 1995;113:1514–7.CrossRefPubMed
8.
Zurück zum Zitat Mirza ZN, Tokuyama K, Arakawa H, Kato M, Mochizuki H, Morikawa A. Inhaled procaterol inhibits histamine-induced airflow obstruction and microvascular leakage in guinea-pig airways with allergic inflammation. Clin Exp Allergy. 1998;28:644–52.CrossRefPubMed Mirza ZN, Tokuyama K, Arakawa H, Kato M, Mochizuki H, Morikawa A. Inhaled procaterol inhibits histamine-induced airflow obstruction and microvascular leakage in guinea-pig airways with allergic inflammation. Clin Exp Allergy. 1998;28:644–52.CrossRefPubMed
9.
Zurück zum Zitat Wang XS, Lau HY. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells. Clin Exp Pharmacol Physiol. 2006;33:746–50.CrossRefPubMed Wang XS, Lau HY. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells. Clin Exp Pharmacol Physiol. 2006;33:746–50.CrossRefPubMed
10.
Zurück zum Zitat Walker RJ, Steinle JJ. Role of beta-adrenergic receptors in inflammatory marker expression in Müller cells. Invest Ophthalmol Vis Sci. 2007;48:5276–81.CrossRefPubMed Walker RJ, Steinle JJ. Role of beta-adrenergic receptors in inflammatory marker expression in Müller cells. Invest Ophthalmol Vis Sci. 2007;48:5276–81.CrossRefPubMed
11.
Zurück zum Zitat Kitazawa Y, Taniguchi T, Sugiyama K. Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy. Ophthalmic Surg. 1989;20:49–52.PubMed Kitazawa Y, Taniguchi T, Sugiyama K. Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy. Ophthalmic Surg. 1989;20:49–52.PubMed
12.
Zurück zum Zitat Sridharrao B, Badrinath SS. Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery. Br J Ophthalmol. 1989;73:884–7.PubMedCentralCrossRefPubMed Sridharrao B, Badrinath SS. Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery. Br J Ophthalmol. 1989;73:884–7.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Araie M, Ishii K. Effects of apraclonidine on intraocular pressure and blood-aqueous barrier permeability after phacoemulsification and intraocular lens implantation. Am J Ophthalmol. 1993;15(116):67–71.CrossRef Araie M, Ishii K. Effects of apraclonidine on intraocular pressure and blood-aqueous barrier permeability after phacoemulsification and intraocular lens implantation. Am J Ophthalmol. 1993;15(116):67–71.CrossRef
14.
Zurück zum Zitat Hayasaka Y, Hayasaka S, Zhang XY, Nagaki Y. Effects of topical antiglaucoma eye drops on prostaglandin E (2)-induced aqueous flare elevation in pigmented rabbits. Invest Ophthalmol Vis Sci. 2002;43:1142–5.PubMed Hayasaka Y, Hayasaka S, Zhang XY, Nagaki Y. Effects of topical antiglaucoma eye drops on prostaglandin E (2)-induced aqueous flare elevation in pigmented rabbits. Invest Ophthalmol Vis Sci. 2002;43:1142–5.PubMed
15.
Zurück zum Zitat Byles DB, Frith P, Salmon JF. Anterior uveitis as a side effect of topical brimonidine. Am J Ophthalmol. 2000;130:287–91.CrossRefPubMed Byles DB, Frith P, Salmon JF. Anterior uveitis as a side effect of topical brimonidine. Am J Ophthalmol. 2000;130:287–91.CrossRefPubMed
16.
Zurück zum Zitat Becker HI, Walton RC, Diamant JI, Zegans ME. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2 % brimonidine tartrate. Arch Ophthalmol. 2004;122:1063–6.CrossRefPubMed Becker HI, Walton RC, Diamant JI, Zegans ME. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2 % brimonidine tartrate. Arch Ophthalmol. 2004;122:1063–6.CrossRefPubMed
17.
Zurück zum Zitat Nguyen EV, Azar D, Papalkar D, McCluskey P. Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features. J Glaucoma. 2008;17:40–2.CrossRefPubMed Nguyen EV, Azar D, Papalkar D, McCluskey P. Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features. J Glaucoma. 2008;17:40–2.CrossRefPubMed
18.
Zurück zum Zitat McKnight CM, Richards JC, Daniels D, Morgan WH. Brimonidine (Alphagan) associated anterior uveitis. Br J Ophthalmol. 2012;96:766–8.CrossRefPubMed McKnight CM, Richards JC, Daniels D, Morgan WH. Brimonidine (Alphagan) associated anterior uveitis. Br J Ophthalmol. 2012;96:766–8.CrossRefPubMed
19.
Zurück zum Zitat Camras CB, Bito LZ, Eakins KE. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest Ophthalmol Vis Sci. 1977;16:1125–34.PubMed Camras CB, Bito LZ, Eakins KE. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest Ophthalmol Vis Sci. 1977;16:1125–34.PubMed
20.
Zurück zum Zitat Watanabe K, Hirata H, Hiraki S, Hayasaka S. Decreased aqueous-flare reaction to repeated applications of prostaglandin E2 to the cornea in pigmented rabbits. Ophthalmic Res. 1996;28:147–52.CrossRef Watanabe K, Hirata H, Hiraki S, Hayasaka S. Decreased aqueous-flare reaction to repeated applications of prostaglandin E2 to the cornea in pigmented rabbits. Ophthalmic Res. 1996;28:147–52.CrossRef
21.
Zurück zum Zitat Sawa M, Tsurimaki Y, Tsuru T, Shimizu H. New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol. 1988;32:132–42.PubMed Sawa M, Tsurimaki Y, Tsuru T, Shimizu H. New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol. 1988;32:132–42.PubMed
22.
Zurück zum Zitat Yanagawa Y, Matsumoto M, Togashi H. Enhanced dendritic cell antigen uptake via alpha2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J Immunol. 2010;185:5762–8.CrossRefPubMed Yanagawa Y, Matsumoto M, Togashi H. Enhanced dendritic cell antigen uptake via alpha2 adrenoceptor-mediated PI3K activation following brief exposure to noradrenaline. J Immunol. 2010;185:5762–8.CrossRefPubMed
23.
Zurück zum Zitat Takayama J, Mayama C, Mishima A, Nagahara M, Tomidokoro A, Araie M. Topical phenilephrine decreases blood velocity in the optic nerve head increases resistive index in the retinal arteries. Eye. 2009;23:827–34.CrossRefPubMed Takayama J, Mayama C, Mishima A, Nagahara M, Tomidokoro A, Araie M. Topical phenilephrine decreases blood velocity in the optic nerve head increases resistive index in the retinal arteries. Eye. 2009;23:827–34.CrossRefPubMed
24.
Zurück zum Zitat Ebbinghaus M, Gajda M, Boettger MK, Schaible HG, Bräuer R. The anti-inflammatory effects of sympathectomy in murine antigeninduced Arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis. 2012;71:253–61.CrossRefPubMed Ebbinghaus M, Gajda M, Boettger MK, Schaible HG, Bräuer R. The anti-inflammatory effects of sympathectomy in murine antigeninduced Arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis. 2012;71:253–61.CrossRefPubMed
25.
Zurück zum Zitat Shiose Y. Electron microscopic studies on blood-retinal and blood-aqueous barriers. Jpn J Ophthalmol. 1970;14:73–87. Shiose Y. Electron microscopic studies on blood-retinal and blood-aqueous barriers. Jpn J Ophthalmol. 1970;14:73–87.
26.
Zurück zum Zitat Bill A. The blood-aqueous barrier. Trans Ophthalmol Soc UK. 1986;105:149–55.PubMed Bill A. The blood-aqueous barrier. Trans Ophthalmol Soc UK. 1986;105:149–55.PubMed
28.
Zurück zum Zitat Kosaka T, Mishima HK, Kiuchi Y, Kataoka K. The effects of prostaglandins on the blood-ocular barrier. Jpn J Ophthalmol. 1995;39:368–76.PubMed Kosaka T, Mishima HK, Kiuchi Y, Kataoka K. The effects of prostaglandins on the blood-ocular barrier. Jpn J Ophthalmol. 1995;39:368–76.PubMed
29.
Zurück zum Zitat Green K, Kim K. Pattern of ocular response to topical and systemic prostaglandin. Invest Ophthalmol. 1975;14:36–40.PubMed Green K, Kim K. Pattern of ocular response to topical and systemic prostaglandin. Invest Ophthalmol. 1975;14:36–40.PubMed
Metadaten
Titel
Effects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbits
verfasst von
Momoko Nakamura-Shibasaki
Miftahul Akhyar Latief
Ji-ae Ko
Kunihiko Funaishi
Yoshiaki Kiuchi
Publikationsdatum
01.03.2016
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 2/2016
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-016-0428-2

Weitere Artikel der Ausgabe 2/2016

Japanese Journal of Ophthalmology 2/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.